Article Text

Download PDFPDF

Original article
Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases
  1. Shaun M Flint1,2,
  2. Vojislav Jovanovic3,
  3. Boon Wee Teo4,
  4. Anselm Mak4,
  5. Julian Thumboo5,
  6. Eoin F McKinney1,2,
  7. James C Lee1,2,
  8. Paul MacAry3,
  9. David M Kemeny3,
  10. David RW Jayne1,
  11. Kok Yong Fong5,
  12. Paul A Lyons1,2 and
  13. Kenneth GC Smith1,2,4
  1. 1Department of Medicine, The University of Cambridge, Cambridge, UK
  2. 2Cambridge Institute of Medical Research, The University of Cambridge, Cambridge, UK
  3. 3Immunology Programme and Department of Microbiology Centre for Life Sciences, National University of Singapore, Singapore, Singapore
  4. 4Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
  5. 5Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore
  1. Correspondence to Professor Kenneth GC Smith; kgcs2{at}cam.ac.uk

Abstract

Objectives Type 1 interferons (IFN-1) are implicated in the pathogenesis of systemic lupus erythematosus (SLE), but most studies have only reported the effect of IFN-1 on mixed cell populations. We aimed to define modules of IFN-1-associated genes in purified leucocyte populations and use these as a basis for a detailed comparative analysis.

Methods CD4+ and CD8+ T cells, monocytes and neutrophils were purified from patients with SLE, other immune-mediated diseases and healthy volunteers and gene expression then determined by microarray. Modules of IFN-1-associated genes were defined using weighted gene coexpression network analysis. The composition and expression of these modules was analysed.

Results 1150 of 1288 IFN-1-associated genes were specific to myeloid subsets, compared with 11 genes unique to T cells. IFN-1 genes were more highly expressed in myeloid subsets compared with T cells. A subset of neutrophil samples from healthy volunteers (HV) and conditions not classically associated with IFN-1 signatures displayed increased IFN-1 gene expression, whereas upregulation of IFN-1-associated genes in T cells was restricted to SLE.

Conclusions Given the broad upregulation of IFN-1 genes in neutrophils including in some HV, investigators reporting IFN-1 signatures on the basis of whole blood samples should be cautious about interpreting this as evidence of bona fide IFN-1-mediated pathology. Instead, specific upregulation of IFN-1-associated genes in T cells may be a useful biomarker and a further mechanism by which elevated IFN-1 contributes to autoimmunity in SLE.

  • Systemic Lupus Erythematosus
  • Autoimmunity
  • Cytokines

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.